Clinical Trial: Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Share this article:
Clinical Trial: Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Sponsor and Collaborator

University of Wisconsin, Madison
Harry Gray Cancer Center Hartford Hospial
M.D. Anderson Cancer Center
University of Illinois
University of Wisconsin Carbone Cancer Center

Contact
Contact: Helene McDowell, M.S.
1-800-3615481
helene.mcdowell@chess.wisc.edu

Contact: Gina Landucci, B.S.
1-800-3615481
gina.landucci@chess.wisc.edu

Principal Investigator
James Cleary, M.D. University of Wisconsin Carbone Cancer Center

Lori DuBenske, Ph.D. University of Wisconsin Carbone Cancer Center

ClinicalTrials.gov Identifier

NCT01012401

Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Lung Cancer Clinical Trials

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment ...

Clinical trial focusing on protein and RNA expression patterns. Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical trial focusing on breathlessness in lung cancer patients. Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood ...

Clinical trial focusing on lung cancer screening. Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker